Copyright
©The Author(s) 2024.
World J Methodol. Mar 20, 2024; 14(1): 89196
Published online Mar 20, 2024. doi: 10.5662/wjm.v14.i1.89196
Published online Mar 20, 2024. doi: 10.5662/wjm.v14.i1.89196
Metabolite | Pathway | Microbial agent | Health benefits |
Butyrate | Carbohydrate metabolism | Clostridia; Faecalibacterium prausnitzii; Coprococcus catus; Anaerostipes hadrus | Increased intestinal barrier function; Modulate intestinal macrophage function; Suppression of colonic inflammation; Improvements in insulin sensitivity |
Propionate | Carbohydrate metabolism | Blautia obeum; Coprococcus catus; Roseburia inulinivorans; Prevotella copri | Suppression of colonic inflammation; Decreased innate immune response to microbial stimulation; Protection from allergic airway inflammation; Improvements in insulin sensitivity and weight control in obese mice |
Indole | Tryptophan metabolism | Lactobacillus; Bifinobacterium longum; Bacteroides fragilis | Maintenance of host-microbe homeostasis at mucosal surfaces via IL-22; Increased barrier function; Modulation of host metabolism |
Indole-3-aldehyde | Tryptophan metabolism | Lactobacillus | Maintenance of mucosal homeostasis and intestinal barrier function via increased IL-22 production; Protection against intestinal inflammation in mouse models of colitis |
Indole-3-propionate | Tryptophan metabolism | Clostridium sporogenes | Maintenance of intestinal barrier function and mucosal homeostasis; Increased production of antioxidant and neuroprotectant products |
10-hydroxy-cis-12-octadecoate | Linoleic acid derivative (lipid metabolism) | Lactobacillus | Maintenance of intestinal barrier function; Decreased inflammation; Increased intestinal IgA production |
- Citation: Salvadori M, Rosso G. Update on the gut microbiome in health and diseases. World J Methodol 2024; 14(1): 89196
- URL: https://www.wjgnet.com/2222-0682/full/v14/i1/89196.htm
- DOI: https://dx.doi.org/10.5662/wjm.v14.i1.89196